About: Anti-NMDA receptor encephalitis presenting as new onset refractory status epilepticus in COVID-19

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Anti-NMDA receptor encephalitis presenting as new onset refractory status epilepticus in COVID-19 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Anti-NMDA receptor encephalitis presenting as new onset refractory status epilepticus in COVID-19
Creator	Bedin, Roberta Bertellini, Elisabetta Giovannini, Giada Marudi, Andrea Melegari, Alessandra Meletti, Stefano Monti, Giulia Pignatti, Alessandro Santangelo, Mario Simone, Anna Trenti, Tommaso
Source	Elsevier; Medline; PMC
abstract	• Autoimmune encephalitis and status epilepticus in COVID-19 can be challenging. • Immunotherapy could be useful for anti-NMDAr encephalitis and SARS-Cov-2 infection. • Cytokines storm could play a role for NORSE presentation in NDMA-R encephalitis.
has issue date	2020-07-15(xsd:dateTime)
bibo:doi	10.1016/j.seizure.2020.07.006
bibo:pmid	32688169
has license	no-cc
sha1sum (hex)	d8b4eeb867f3663ad6a0dac09ec7100bedf31e23
schema:url	https://doi.org/10.1016/j.seizure.2020.07.006
resource representing a document's title	Anti-NMDA receptor encephalitis presenting as new onset refractory status epilepticus in COVID-19
has PubMed Central identifier	PMC7362825
has PubMed identifier	32688169
schema:publication	Seizure
resource representing a document's body	covid:d8b4eeb867f3663ad6a0dac09ec7100bedf31e23#body_text
is schema:about of	named entity 'lacosamide' named entity 'FIRES' named entity 'alpha rhythm' named entity 'bacteria' named entity 'antibodies' named entity 'encephalitis' named entity 'COVID-19 infection' named entity 'phenytoin' named entity 'encephalitis' named entity 'cytokines' named entity 'fungi' named entity 'autoimmune encephalitis' named entity 'brain MRI' named entity 'COVID' named entity 'SARS-CoV-2' named entity 'PCR' named entity 'Status Epilepticus' named entity 'phenobarbital' named entity 'refractory' named entity 'plasma-exchange' named entity 'epileptic patients' named entity 'Bio-Techne' named entity 'plasma levels' named entity 'neurotropic' named entity 'medical history' named entity 'IL8' named entity 'infection' named entity 'autoimmune encephalitis' named entity 'hydroxychloroquine' named entity 'herpes viruses' named entity 'Titin' named entity 'IL6' named entity 'Il6' named entity 'infection' named entity 'plasma-exchange' named entity 'Recoverin' named entity 'psychiatric symptoms' named entity 'SARS-CoV-2' named entity 'SARS-CoV-2' named entity 'lopinavir/ritonavir' named entity 'pathogenetic' named entity 'SARS-CoV-2' named entity 'COVID' named entity 'infection' named entity 'seizures' named entity 'antivirals' named entity 'case report' named entity 'infection' named entity 'status epilepticus' named entity 'immunoassays' named entity 'throat swab' named entity 'pro-inflammatory cytokines' named entity 'cough' named entity 'valproic acid' named entity 'CSF' named entity 'informed consent' named entity 'SARS-CoV-2' named entity 'refractory' named entity 'refractory' named entity 'HSV1' named entity 'neurologic' named entity 'CRP' named entity 'infection' named entity 'fever' named entity 'immunosuppression' named entity 'steroids' named entity 'dexamethasone' named entity 'inflammatory' named entity 'immunoassays' named entity 'infection' named entity 'antiseizure medications'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software